'Now your total return in stock markets is going to come much more from dividends': Wall Street fundie

This 30-year veteran of investing says this market correction will be long.

| More on:
A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Veteran Wall Street fundie Rupal Bhansali says it's time to "reposition portfolios from growth to value" 
  • She argues that high-interest rates will prompt a long sell-off period for growth stocks, therefore making ASX dividend shares more appealing 
  • Bhansali likes healthcare stocks and companies with low debt, and recommends avoiding cyclical shares for income in this economic climate

Veteran Wall Street fundie Rupal Bhansali says it's time to "reposition portfolios from growth to value" as high-interest rates make dividends more important for ASX share investors.

Bhansali, the chief investment officer at Ariel Investments, is in Australia visiting institutional clients.

In the Australian Financial Review (AFR), Bhansali says she is "very bearish" on the United States and Australian share markets.

This is because earnings expectations are too high, and valuations are too rich for this economic climate.

She explains that high-interest rates will likely spawn a protracted sell-off in growth stocks. She mentioned that many of them are trading on high valuations already.

Bhansali believes interest rates will be higher for longer, and this correction will be "death by a thousand cuts".

She explains that the recent rebound, which began in mid-June 2022 and caused a 12% spike in the S&P/ASX 200 Index (ASX: XJO), was a 'bear market rally'.

Bhansali is not alone in her thinking. Australian fundie Michael O'Neill of Investors Mutual recently wrote that capital growth will likely be lower for ASX shares over the next decade, making dividends "critical".

Which ASX dividend shares should you buy?

Bhansali hinted at which companies are worth targeting and which are best avoided.

She said:

Now your total return in stockmarkets is going to come much more from dividends, I favour companies that don't have a lot of debt, indebted companies should trade at a discount to net cash companies, but they're not, so my portfolio is much more biased towards owning net cash companies.

Getting more specific, Bhansali said healthcare companies offered solid dividends and returns.

The ASX has 180 healthcare companies listed today.

The biggest ASX healthcare shares by market capitalisation are CSL Limited (ASX: CSL), Sonic Healthcare Limited (ASX: SHL), and Ramsay Health Care Ltd (ASX: RHC). They are trading on dividend yields of 1.12%, 3.18%, and 1.47% respectively, according to the ASX website.

She also pointed out that buying any stocks denominated in euros or British pounds today would likely deliver foreign exchange gains when sold down the track.

O'Neill favours "quality industrial companies, at attractive valuations, that pay strong dividend yields".

The ASX has 164 industrial sector companies listed today.

The biggest industrial shares are Transurban Group (ASX: TCL), Brambles Limited (ASX: BXB), and Auckland International Airport Limited (ASX: AIA). They are trading on dividend yields of 3.74%, 2.67%, and 0% (since COVID-19) respectively, according to the ASX website.

Which ASX shares are worth avoiding?

Bhansali said the recent 40% dividend cut by ASX 200 blue-chip share BHP Group Ltd (ASX: BHP) showed why investing in cyclical businesses for future income is dangerous.

O'Neill also recommends avoiding overweight positions in cyclical shares, including ASX resources stocks, and commercial property.


Motley Fool contributor Bronwyn Allen has positions in BHP Group and CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Three analysts look at tech options on a wall screen
Technology Shares

Up 70%, is it too late to invest in Xero shares?

This ASX tech darling hit a new all-time share price record yesterday.

Read more »

Four people on the beach leap high into the air.
Broker Notes

4 ASX All Ords shares offering 10% to 30% annual growth: brokers

These ASX All Ords stocks have caught the eye of brokers this week.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Here are 2 ASX shares that Morgans rates as buys

Let's see why the broker is feeling bullish on these stocks.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

Guess which ASX 200 stock was just upgraded to a buy rating

Why did the broker just turn bullish? Let's find out.

Read more »

Two brokers analysing stocks.
Broker Notes

Don't miss these changes to broker ratings on ASX shares

The verdicts are in.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

Read more »

man thinking about whether to invest in bitcoin
Broker Notes

Why now is the time to buy this beaten down $8b ASX 200 stock

Goldman Sachs thinks that now is the time to invest in this beaten down drinks giant.

Read more »